BIOS IT4 DATASET
Visualisation by Andreas Nicolas Fischer
BIOS has launched a flagship programme to realise a neural-cardiac therapy in partnership with the top pharma R&D, academic and technology organisations in the world.
AUTONOMIC
THERAPY INITIATIVE
CARDIAC DISEASE IS OUR BIGGEST HEALTH CRISIS WITH FEW EFFECTIVE DRUGS
Cardiovascular diseases are responsible for a third of all deaths globally.
​
However, new cardiovascular disease therapies are very rare due to the high cost and long timescale of trials and the 10,000 to 1 failure rate of new pharmaceutical compounds.
OUR BEACHHEAD WILL BE
TO SURPASS THE BETA BLOCKER FOR CARDIAC DISEASE
By understanding and correcting signals in real time, we can treat chronic cardiac illnesses in an effective, automated and personalized way.
​
Neural interfaces can be used to form a direct connection with the neurons around the heart and other organs, which offers a whole new class of treatments for cardiovascular disease.
WHEN WE CAN CONTROL OUR NEURAL SIGNALS WE CAN PREVENT THE DETERIORATION IN OUR HEALTH
ECG
RESPIRATORY PRESSURE
BLOOD GLUCOSE
THE AUTONOMIC THERAPY INITIATIVE IS POWERED BY DIGITAL NEURAL BIOMARKERS
BIOS uses neural interfaces & AI to discover the language of the nervous system - a code known as digital neural biomarkers
​
The Autonomic Therapy Initiative (ATI) leverages these unique neural biomarkers to offer precision unseen before in healthcare - giving personalised, real-time treatment recommendations, shaping the design of new therapies and even replacing current drugs with computer generated neural signals
LEARN MORE ABOUT OUR TECHNOLOGY
ATI LEADERSHIP
EMIL HEWAGE
BIOS CEO & Founder
OLIVER ARMITAGE
BIOS CSO & Founder
PROF. JOANNE HACKETT
BIOS Board Chair
ATI ADVISORY PANEL
PROF. TIM DENISON
Royal Academy of Engineering Chair in BioEngineering at the University of Oxford
(Advisory Panel Chair)
PROF. DAVID PATERSON
Head of Dept of Physiology, Anatomy & Genetics at the University of Oxford
MONA FLORES MD
Global Head of Medical AI
at Nvidia
DR. CEM BAYDAR
Head of Portfolio Strategy & Consulting Services at IQVIA
Our vision is a future where we have control over our bodies and lives, enabling radically improved, seamlessly experienced healthcare.
DIGITAL NEURAL
BIOMARKERS
THOUSANDS OF POSSIBLE
TREATMENTS
Interested in collaborating or learning more about the ATI programme?
Contact us at info@BIOS.health
or fill in the form opposite.
Interested in working with us?
Take a look at our current vacancies or contact us at careers@BIOS.health
​
Privacy Policy - Terms and Conditions - Financial Conflicts of Interest Policy
